恒古骨伤愈合剂口服联合透药治疗腰椎间盘突出症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R246.9

基金项目:

全国名老中医药专家仇湘中传承工作室建设项目(国中医药人教〔2016〕42号);湖南省科技厅项目(2021018);湖南中医药研究院 重点课题(202003)


Clinical Study on Oral Administration and Penetration of Henggu Gushang Healing Agent for Lumbar Disc Herniation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察恒古骨伤愈合剂口服联合透药治疗腰椎间盘突出症(LDH) 临床疗效。方法:选取93 例LDH 患者,按随机数字表法分为联合组、透药组、口服组各31 例。联合组采取口服恒古骨伤愈合剂联合定向透药恒古骨伤愈合剂治疗,透药组采取定向透药恒古骨伤愈合剂治疗,口服组采取口服恒古骨伤愈合剂治疗。2 天1 次,4 次为1 个疗程,3 组均连续治疗4 个疗程。比较3 组临床疗效,比较3 组治疗前后疼痛视觉模拟评分法(VAS)、功能障碍指数评分表(ODI) 评分的变化。结果:治疗后,3 组VAS 评分均较治疗前下降,差异均有统计学意义(P<0.05);治疗后,联合组VAS 评分低于透药组、口服组,差异均有统计学意义(P<0.05)。治疗后,3 组ODI 评分均较治疗前下降,差异均有统计学意义(P<0.05);治疗后,联合组ODI 评分低于透药组、口服组,差异均有统计学意义(P<0.05)。联合组临床疗效总有效率为90.32%,透药组总有效率为74.19%,口服组总有效率为70.97%。联合组总有效率高于透药组及口服组,差异均有统计学意义(P<0.05)。结论:恒古骨伤愈合剂口服联合透药治疗LDH 能改善患者临床症状,有效降低LDH 患者疼痛程度,缓解LDH 活动受限症状,疗效显著。

    Abstract:

    Abstract: Objective: To observe the clinical effect of oral administration and penetration of Henggu Gushang healing agent for lumbar disc herniation(LDH). Methods:A total of 93 cases of LDH patients were divided into the combination group, the penetration group and the oral administration group according to the random number table method,with 31 cases in each group. The combination group was treated with oral administration and directional penetration of Henggu Gushang healing agent, the penetration group was treated with directional penetration of Henggu Gushang healing agent, and the oral administration group was treated with oral administration of Henggu Gushang healing agent. Treatment was given once every two days,and all groups were treated for four courses,with four times being a course. The clinical effects in the three groups were compared. Before and after treatment, the changes in levels of Visual Analogue Scale(VAS) and Oswestry Disability Index(ODI) in the three groups were compared. Results:After treatment, the VAS scores in the three groups were decreased when compared with those before treatment,differences being significant(P<0.05);the VAS score in the combination group was lower than those in the penetration group and the oral administration group,the difference being significant(P<0.05). After treatment, the ODI scores in the three groups were decreased when compared with those before treatment,differences being significant(P<0.05);the ODI score in the combination group was lower than those in the penetration group and the oral administration group,the difference being significant(P<0.05). The total effective rate of clinical effect was 90.32% in the combination group,74.19% in the penetration group and 70.97% in the oral administration group. The total effective rate in the combination group was higher than those in the penetration group and the oral administration group,the difference being significant (P<0.05). Conclusion:Oral administration and penetration of Henggu Gushang healing agent for LDH can improve the clinical symptoms, and effective relieve pain and limitation of movement of LDH, with a significant clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

叶子丰,匡浩铭,沈琳玲,安娟,戎宽,匡建军.恒古骨伤愈合剂口服联合透药治疗腰椎间盘突出症临床研究[J].新中医,2022,54(13):83-87

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-07-07
  • 出版日期:
文章二维码